US Patent Issued to Merck Patent on Dec. 2 for "Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer" (German Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,260, issued on Dec. 2, was assigned to Merck Patent GmbH (Darmstadt, Germany).

"Indazolyl-isoxazole derivatives for the treatment of diseases such as cancer" was invented by Dieter Dorsch (Ober-Ramstadt, Germany) and Andreas Blum (Bensheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds of the formula Iare provided. These compounds can inhibit c-Kit kinase and can be employed for the treatment of cancer."

The patent was filed on Feb. 10, 2020, under Application No. 17/429,938.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fneta...